| SAR millions | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|
| Revenue | 20.0 | 19.2 | 22.3 | +16.0% | |
| Cost of revenue | 5.4 | 4.8 | 8.3 | +71.4% | |
| Gross profit | 14.6 | 14.4 | 14.0 | −2.6% | |
| Research & development | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 0.0 | 2.8 | 0.0 | −100.0% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 0.9 | 2.8 | 0.5 | −81.0% | |
| Operating income | 13.7 | 11.6 | 13.5 | +16.4% | |
| Interest expense | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.4 | — | |
| Other income / expense | (0.1) | (0.0) | 0.3 | +7190.6% | |
| Pre-tax income | 13.6 | 11.6 | 13.8 | +18.7% | |
| Income tax | 0.0 | 0.0 | 0.0 | — | |
| Net income | 13.6 | 11.6 | 13.8 | +18.7% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 0.91 | 0.77 | 0.70 | −9.1% | |
| EPS, diluted (per share) | 0.91 | 0.77 | 0.70 | −9.1% | |
| EBITDA | 14.9 | 12.7 | 16.2 | +27.0% | |
| Depreciation & amortization | 1.2 | 1.1 | 2.4 | +113.7% | |
| Weighted average shares (shares) | 15,000,000 | 15,000,000 | 19,790,954 | +31.9% | |
| Weighted average diluted shares (shares) | 15,000,000 | 15,000,000 | 19,790,954 | +31.9% | |
| Gross margin | 73.0% | 74.9% | 63.0% | −12.0 pts | |
| Operating margin | 68.6% | 60.3% | 60.6% | +0.2 pts | |
| Net margin | 68.1% | 60.3% | 61.7% | +1.4 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
